|
Volumn 3, Issue 2, 2001, Pages 217-223
|
Perceived benefit after participating in positive or negative/neutral heart failure trials: The patients' perspective
|
Author keywords
Clinical trials; Patient benefit; Patient perception; Placebo effect
|
Indexed keywords
4,5 DIHYDRO 6 [4 (4 PYRIDYLAMINO)PHENYL] 3(2H) PYRIDAZINONE;
BOSENTAN;
CALCIUM SENSITIZER;
CANDESARTAN HEXETIL;
CARVEDILOL;
ENKEPHALINASE INHIBITOR;
MIBEFRADIL;
PLACEBO;
SINORPHAN;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOCTOR PATIENT RELATION;
FEMALE;
HEART FAILURE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
META ANALYSIS;
PATIENT ATTITUDE;
PATIENT COMPLIANCE;
PATIENT RIGHT;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
AGED;
CARDIOTONIC AGENTS;
FEMALE;
HEART FAILURE, CONGESTIVE;
HUMANS;
MALE;
MIDDLE AGED;
PATIENT EDUCATION;
PATIENT PARTICIPATION;
PATIENT SATISFACTION;
PLACEBO EFFECT;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
EID: 0035100350
PISSN: 13889842
EISSN: None
Source Type: Journal
DOI: 10.1016/S1388-9842(00)00151-3 Document Type: Article |
Times cited : (14)
|
References (23)
|